FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2961605542> ?p ?o ?g. }

• W2961605542 endingPage "3364" @default.
• W2961605542 startingPage "3364" @default.
• W2961605542 abstract "Glioblastoma is the most common and malignant primary brain tumour in adults, with a dismal prognosis. This is partly due to considerable inter- and intra-tumour heterogeneity. Changes in the cellular energy-producing mitochondrial respiratory chain complex (MRC) activities are a hallmark of glioblastoma relative to the normal brain, and associate with differential survival outcomes. Targeting MRC complexes with drugs can also facilitate anti-glioblastoma activity. Whether mutations in the mitochondrial DNA (mtDNA) that encode several components of the MRC contribute to these phenomena remains underexplored. We identified a germ-line mtDNA mutation (m. 14798T > C), enriched in glioblastoma relative to healthy controls, that causes an amino acid substitution F18L within the core mtDNA-encoded cytochrome b subunit of MRC complex III. F18L is predicted to alter corresponding complex III activity, and sensitivity to complex III-targeting drugs. This could in turn alter reactive oxygen species (ROS) production, cell behaviour and, consequently, patient outcomes. Here we show that, despite a heterogeneous mitochondrial background in adult glioblastoma patient biopsy-derived cell cultures, the F18L substitution associates with alterations in individual MRC complex activities, in particular a 75% increase in MRC complex II_III activity, and a 34% reduction in CoQ10, the natural substrate for MRC complex III, levels. Downstream characterisation of an F18L-carrier revealed an 87% increase in intra-cellular ROS, an altered cellular distribution of mitochondrial-specific ROS, and a 64% increased sensitivity to clomipramine, a repurposed MRC complex III-targeting drug. In patients, F18L-carriers that received the current standard of care treatment had a poorer prognosis than non-carriers (373 days vs. 415 days, respectively). Single germ-line mitochondrial mutations could predispose individuals to differential prognoses, and sensitivity to mitochondrial targeted drugs. Thus, F18L, which is present in blood could serve as a useful non-invasive biomarker for the stratification of patients into prognostically relevant groups, one of which requires a lower dose of clomipramine to achieve clinical effect, thus minimising side-effects." @default.
• W2961605542 created "2019-07-23" @default.
• W2961605542 creator A5003231362 @default.
• W2961605542 creator A5005959767 @default.
• W2961605542 creator A5005970752 @default.
• W2961605542 creator A5006254217 @default.
• W2961605542 creator A5016590264 @default.
• W2961605542 creator A5028735233 @default.
• W2961605542 creator A5036742984 @default.
• W2961605542 creator A5038274735 @default.
• W2961605542 creator A5041217662 @default.
• W2961605542 creator A5042207433 @default.
• W2961605542 creator A5043173438 @default.
• W2961605542 creator A5056730323 @default.
• W2961605542 creator A5072979930 @default.
• W2961605542 creator A5079591293 @default.
• W2961605542 creator A5079958823 @default.
• W2961605542 creator A5087252357 @default.
• W2961605542 date "2019-07-09" @default.
• W2961605542 modified "2023-10-12" @default.
• W2961605542 title "Integrated Approach Reveals Role of Mitochondrial Germ-Line Mutation F18L in Respiratory Chain, Oxidative Alterations, Drug Sensitivity, and Patient Prognosis in Glioblastoma" @default.
• W2961605542 cites W1482016039 @default.
• W2961605542 cites W1528834211 @default.
• W2961605542 cites W1541324451 @default.
• W2961605542 cites W1541799695 @default.
• W2961605542 cites W1737629705 @default.
• W2961605542 cites W1964107465 @default.
• W2961605542 cites W1973925468 @default.
• W2961605542 cites W1976633761 @default.
• W2961605542 cites W1980311312 @default.
• W2961605542 cites W2000647702 @default.
• W2961605542 cites W2001508320 @default.
• W2961605542 cites W2002532393 @default.
• W2961605542 cites W2025719835 @default.
• W2961605542 cites W2026525843 @default.
• W2961605542 cites W2026800490 @default.
• W2961605542 cites W2035979637 @default.
• W2961605542 cites W2045851185 @default.
• W2961605542 cites W2050486415 @default.
• W2961605542 cites W2060965924 @default.
• W2961605542 cites W2063169093 @default.
• W2961605542 cites W2080919844 @default.
• W2961605542 cites W2081208114 @default.
• W2961605542 cites W2101460607 @default.
• W2961605542 cites W2103441770 @default.
• W2961605542 cites W2104431138 @default.
• W2961605542 cites W2112113834 @default.
• W2961605542 cites W2113942802 @default.
• W2961605542 cites W2115174652 @default.
• W2961605542 cites W2116820741 @default.
• W2961605542 cites W2123603473 @default.
• W2961605542 cites W2126511952 @default.
• W2961605542 cites W2127307105 @default.
• W2961605542 cites W2128863631 @default.
• W2961605542 cites W2129550993 @default.
• W2961605542 cites W2129993587 @default.
• W2961605542 cites W2134090669 @default.
• W2961605542 cites W2135465849 @default.
• W2961605542 cites W2138618895 @default.
• W2961605542 cites W2143588920 @default.
• W2961605542 cites W2145489645 @default.
• W2961605542 cites W2145675170 @default.
• W2961605542 cites W2145869806 @default.
• W2961605542 cites W2160514683 @default.
• W2961605542 cites W2161289668 @default.
• W2961605542 cites W2166369346 @default.
• W2961605542 cites W2168133698 @default.
• W2961605542 cites W2170597525 @default.
• W2961605542 cites W2170818431 @default.
• W2961605542 cites W2200718955 @default.
• W2961605542 cites W2393535458 @default.
• W2961605542 cites W2397464012 @default.
• W2961605542 cites W2441832156 @default.
• W2961605542 cites W2515115215 @default.
• W2961605542 cites W2606580606 @default.
• W2961605542 cites W2756387833 @default.
• W2961605542 cites W2793801299 @default.
• W2961605542 cites W962061814 @default.
• W2961605542 doi "https://doi.org/10.3390/ijms20133364" @default.
• W2961605542 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6651022" @default.
• W2961605542 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31323957" @default.
• W2961605542 hasPublicationYear "2019" @default.
• W2961605542 type Work @default.
• W2961605542 sameAs 2961605542 @default.
• W2961605542 citedByCount "9" @default.
• W2961605542 countsByYear W29616055422021 @default.
• W2961605542 countsByYear W29616055422022 @default.
• W2961605542 crossrefType "journal-article" @default.
• W2961605542 hasAuthorship W2961605542A5003231362 @default.
• W2961605542 hasAuthorship W2961605542A5005959767 @default.
• W2961605542 hasAuthorship W2961605542A5005970752 @default.
• W2961605542 hasAuthorship W2961605542A5006254217 @default.
• W2961605542 hasAuthorship W2961605542A5016590264 @default.
• W2961605542 hasAuthorship W2961605542A5028735233 @default.
• W2961605542 hasAuthorship W2961605542A5036742984 @default.
• W2961605542 hasAuthorship W2961605542A5038274735 @default.
• W2961605542 hasAuthorship W2961605542A5041217662 @default.
• W2961605542 hasAuthorship W2961605542A5042207433 @default.

• next